Logo Logo Logo
  • Home
  • About Us
    • Strategic Plan
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
Logo Logo Logo Logo Logo Logo
  • Home
  • About Us
    • Strategic Plan
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
 

November 2011

29 Nov TI Podcast [80]: Dabigatran for atrial fibrillation: Why we can not rely on RE-LY

Posted at 16:23h in Podcasts & Videos 0 Comments
Share

Listen to Alan Cassels interview Dr Aaron Tejani from the Therapeutics Initiative at UBC and Fraser Health regarding the use of dabigatran for atrial fibrilation. Read Therapeutics Letter 80...

Read More

09 Nov ISDB General Assembly Meeting – 2012

Posted at 10:55h in Education 0 Comments
Share

March 25 - 28, 2012Vancouver, BC, Canada ProgramView preliminary program here.Participants will be picked up on March 24 either at the Vancouver Airport (YVR) or Downtown Vancouver and taken by bus to the conference venue. More...

Read More

adverse effects adverse events antibacterial agents antidepressive agents artificial intelligence bias biosimilars blood pressure chronic pain COPD covid-19 deprescribing Deprescriptions Diabetes Diabetes Mellitus Drug-Related Side Effects and Adverse Reactions Drug Costs drug safety gabapentin Glycemic Control guidelines hypertension inappropriate prescribing information dissemination machine learning meta-analysis methods opioid analgesics opioids overdiagnosis pain pharmacoepidemiology portrait pregabalin prescribing proton pump inhibitors publishing safety Sodium-Glucose Transporter 2 Inhibitors statistics substance withdrawal syndrome systematic review systematic reviews tofacitinib tramadol

Therapeutics Initiative logo

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. More about us

The Therapeutics Initiative is part of the Department of Anesthesiology, Pharmacology & Therapeutics at UBC's Faculty of Medicine.

Donate

 

Contact

Therapeutics Initiative
Dept of Anesthesiology, Pharmacology & Therapeutics
Faculty of Medicine
University of British Columbia

300 - 2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3

210 - 1110 Government Street
Victoria, BC, Canada V8W 1Y2

Office: +1 604-822-0700
Send us a message

 

Subscribe for Updates

Want to stay abreast of new therapeutics information? Then subscribe to receive email notices of upcoming Therapeutics Letters, educational events, and other announcements. We promise not to spam you and you won’t hear from us more than a few times a month.

Subscribe

Located on the traditional, ancestral and unceded territory of the hən̓q̓əmin̓əm̓ speaking peoples, including the xʷməθkwəy̓əm (Musqueam), the Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh), and the Skwxwú7mesh (Squamish) Nations, and on the lək̓ʷəŋən (Lekwungen) territory of the Songhees, Esquimalt and W̱SÁNEĆ peoples.

 
© Copyright 1994 - 2026 Therapeutics Initiative | Terms & Policies